Page last updated: 2024-08-26

cyanopindolol and Chronic Disease

cyanopindolol has been researched along with Chronic Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cremaschi, GA; Edgar, VA; Genaro, AM; Sterin-Borda, L1

Other Studies

1 other study(ies) available for cyanopindolol and Chronic Disease

ArticleYear
Altered expression of autonomic neurotransmitter receptors and proliferative responses in lymphocytes from a chronic mild stress model of depression: effects of fluoxetine.
    Brain, behavior, and immunity, 2002, Volume: 16, Issue:4

    Topics: Adrenergic beta-Antagonists; Animals; Antidepressive Agents, Second-Generation; Autonomic Nervous System; B-Lymphocytes; CD4-CD8 Ratio; Cell Division; Chronic Disease; Cyclic AMP; Cyclic GMP; Disease Models, Animal; Female; Fluoxetine; Iodine Radioisotopes; Mice; Mice, Inbred BALB C; Mitogens; Muscarinic Antagonists; Pindolol; Quinuclidinyl Benzilate; Radioligand Assay; Receptors, Adrenergic, beta; Receptors, Muscarinic; Stress, Psychological; T-Lymphocytes; Tritium

2002